Condition: Spinal Cord Injuries · Sponsor: University of Alberta
This study will assess how the serotonin precursor, 5-HTP, alter nervous system excitability and motor function in individuals with spinal cord injuries of differing chronicity and severity. Participants will visit the lab on 4 separate occasions where they will be administered four different drugs in a randomized, double-blinded, placebo-controlled crossover design.
This description comes directly from the study's public registry record.
Jessica D'Amico, PhD · 780-735-7917 · damico1@ualberta.ca
Always discuss trial participation with your own doctor first.
| University of Louisville | Louisville, Kentucky, United States | Completed |
| University of Alberta | Edmonton, Alberta, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04520178